TRANSACTION RECORD

DOWNLOAD RECORD   vCard | CSV | PDF
Company Name EyeCyte
Status Out of Business
Industry Biopharmaceutical
Company Description EyeCyte, Inc., an early stage ophthalmology research and development company based in La Jolla, California, announced that it has secured its seed funding through an agreement with Pfizer. The financing will fund the company to drive product development of the company's initial clinical target, diabetic retinopathy.
Mailing Address 3366 North Torrey Pines Court Suite 130
La JollaCA 92037
USA  Map
Phone (858) 453-5800
Website www.eyecyte.com
Email Click for Free Trial
Profile
Social Media
Company News
Facebook
YouTube
 
Company Management
Title Name Email Profile
     
Chief Executive Officer El-Kalay, Mohammad
VP - R & D Ritter, Matthew
Information Release Date 6/23/2008
Transaction Type Venture Equity
Amount $3,000,000
Round Series A
Proceeds Purposes The financing will fund the company into 2010 and will be primarily used to drive product development of the company’s initial clinical target, diabetic retinopathy.
Transaction Investors
Pfizer Venture Investments
Corey Goodman

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.


PCI - Level1